Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists

被引：4

作者：

de Souza, Cinthia Madeira ^{[1
]}

Visacri, Marilia Berlofa ^{[1
]}

Ferrari, Graziele Baldan ^{[1
]}

Tuan, Bruna Taliani ^{[1
]}

Lourenco Costa, Anna Paula ^{[1
]}

Barbosa, Cristina Rosa ^{[3
]}

Lima, Carmen Silvia P. ^{[2
]}

Mazzola, Priscila Gava ^{[1
]}

Moriel, Patricia ^{[1
]}

机构：

[1] Univ Campinas UNICAMP, Dept Clin Pathol, BR-13083970 Campinas, SP, Brazil

[2] Univ Campinas UNICAMP, Dept Clin Med, Sch Med Sci FCM, BR-13083970 Campinas, SP, Brazil

[3] Univ Campinas UNICAMP, Chemotherapy Preparat Unit, Hosp Clin, BR-13083970 Campinas, SP, Brazil

来源：

INTERNATIONAL JOURNAL OF PHARMACY PRACTICE | 2015年 / 23卷 / 05期

关键词：

antineoplastic treatment; nausea; pharmacists; quality of life; vomiting;

D O I：

10.1111/ijpp.12169

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Objective This study aims to evaluate the frequency and severity of nausea and vomiting using two different instruments and relate them to quality of life (QOL) in patients with cancer receiving antineoplastic treatment. Methods Severity of chemotherapy-induced nausea and vomiting (CINV) was measured by Common Terminology Criteria for Adverse Events (CTCAE) and a numerical scale. QOL was assessed using the Functional Assessment of Cancer Therapy-General questionnaire. Key findings Of the 50 patients studied, 60.0% reported nausea (40.0% CTCAE grade 1; 66.7% moderate intensity on numerical scale) and 30.0% reported vomiting (46.7% CTCAE grades 1 and 2, each; 66.7% moderate intensity on numerical scale). CINV did not influence overall QOL. Conclusion The frequency of CINV was high. There was no association between nausea/vomiting and overall QOL.

引用

页码：357 / 360

页数：4

共 10 条

[1]

[Anonymous], 2010, COMM TERM CRIT ADV E

[2]

[Anonymous], 2004, MANUAL FUNCTIONAL AS

[3] The impact of chemotherapy-induced nausea and vomiting on health-related quality of life [J].

Ballatori, Enzo ;

Roila, Fausto ;

Ruggeri, Benedetta ;

Betti, Maura ;

Sarti, Samanta ;

Soru, Giancarla ;

Cruciani, Giorgio ;

Di Maio, Massimo ;

Andrea, Biffi ;

Deuson, Robert R. .

SUPPORTIVE CARE IN CANCER, 2007, 15 (02) :179-185

[4] Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment [J].

Bloechl-Daum, Brigitte ;

Deuson, Robert R. ;

Mavros, Panagiotis ;

Hansen, Mogens ;

Herrstedt, Jorn .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4472-4478

[5]

Bruera E, 1991, J Palliat Care, V7, P6

[6] Drug therapy: Chemotherapy-induced nausea and vomiting [J].

Hesketh, Paul J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (23) :2482-2494

[7] Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: Past, present, and future recommendations [J].

Jordan, Karin ;

Sippel, Christoph ;

Schmoll, Hans-Joachim .

ONCOLOGIST, 2007, 12 (09) :1143-1150

[8]

Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P325

[9]

Poddar S., 2009, DHAKA U J PHARMA SCI, V8, P11

[10] Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus Conference [J].

Roila, F ;

Hesketh, PJ ;

Herrstedt, J .

ANNALS OF ONCOLOGY, 2006, 17 (01) :20-28

← 1 →